Ingenovis Health comprehensive restructuring transactions
We advised Ingenovis Health in connection with the restructuring
Experience
To find Davis Polk deals and cases of particular interest, select filters based on practice, industry, region, lawyer and keyword.
Filters
Over $5.2 billion of hybrid and structured capital financings in Q1 2026
We advised on 20 hybrid and structured capital financings in the first quarter
Anthology chapter 11 restructuring
We advised an ad hoc group of creditors on the restructuring
LXO Group hybrid capital acquisition financing
We advised Hayfin Capital Management on its hybrid capital investment in LXO Group
Over $11.4 billion of hybrid and structured capital financings in 2025
We advised on more than 50 hybrid and structured capital financings
Pharmaceutical company $550 million preferred equity acquisition financing
We advised the preferred equity financing sources on the transaction
Over $7.4 billion of hybrid and structured capital financings year to date
We advised on more than 40 structured and hybrid capital financings in the first three quarters of 2025
Credit facilities and preferred equity financing amendments for a software company
We advised the agent, lender and investor on the transaction
$398 million equity investments in a music rights organization
We advised the investor on the preferred equity and common equity investments
Over 60 hybrid and structured capital transactions since 2024
We advised on approximately $16 billion of hybrid and structured capital financings